title: [Allergic contact eczema].
abstract: Allergic contact eczema due to type IV reactions are more frequent than irritative eczema in facial skin, particularly in the sensitive periorbital region. Concomitant eczema of different locations is pathognomonic and allows a distinction from seborrhoic dermatitis. Avoidance of allergen exposure is mandatory for an effective treatment; therefore allergological examinations have a very high significance. Patch tests with a wide spectrum of potential allergens have to be included in these tests. Therapeutic regimes include a restrictive use of topical steroids. Substances like calcineurin inhibitors are the first-line therapy in facial atopic dermatitis, in spite of therapeutic effects, they have not yet been approved for other forms of periorbital dermatitis.
authors.affiliation: Klinik für Hautkrankheiten, Ambulanz für Allergologie, Berufsdermatologie und Umweltmedizin, Universitätsklinikum Münster.
authors.forename: R
authors.initials: R
authors.lastname: Brehler
authors.affiliation: Klinik für Hautkrankheiten, Ambulanz für Allergologie, Berufsdermatologie und Umweltmedizin, Universitätsklinikum Münster.
authors.forename: S
authors.initials: S
authors.lastname: Grundmann
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D009916:Orbital Diseases / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents